Related Experiment Video
Updated: Mar 8, 2026
Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Advancements in Diagnosing Periprosthetic Joint Infections after Total Hip and Knee Arthroplasty
Ripal Patel1, Pouya Alijanipour1, Javad Parvizi1
1Rothman Institute at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Abstract:
Periprosthetic joint infection (PJI) is a complication of total joint arthroplasty that is challenging to diagnose. Currently, there is no "gold standard" for definite diagnosis of PJI. A multi-criteria definition has been described for PJI based on microbiology cultures, serum markers, such as erythrocyte sedimentation rate and C-reactive protein (CRP), synovial fluid biomarkers, such as leukocyte esterase and histopathology assessment of the periprosthetic tissue. The conventional serum markers are generally nonspecific and can be elevated in inflammatory conditions. Therefore, they cannot be relied on for definite diagnosis of PJI. Hence, with the use of proteomics, synovial fluid biomarkers such as α-defensin, IL-6, and CRP have been proposed as more accurate biomarkers for PJI. Current methods to culture micro-organisms have several limitations, and can be false-negative and false-positive in a considerable number of cases. In an attempt to improve culture sensitivity, diagnostic methods to target biofilms have recently been studied. The understanding of the concept of biofilms has also allowed for the development of novel techniques for PJI diagnosis, such as visualizing biofilms with fluorescent in-situ hybridization and detection of bacteria via DNA microarray. Lastly, the use of amplification-based molecular techniques has provided methods to identify specific species of bacteria that cause culture-negative PJI. While diagnosing PJI is difficult, these advances could be valuable tools for clinicians.
Insights
Diagnosing periprosthetic joint infection (PJI) remains difficult. Novel biomarkers and techniques, including proteomics and molecular methods, show promise for improving PJI detection accuracy.
Area of Science:
- Orthopedic surgery
- Infectious diseases
- Biomarker discovery
Background:
- Periprosthetic joint infection (PJI) is a significant complication following total joint arthroplasty.
- Current diagnostic methods for PJI lack a definitive "gold standard" and often yield unreliable results.
- Conventional serum markers (e.g., CRP) are nonspecific and can be elevated in non-infectious inflammatory states.
Purpose of the Study:
- To review current challenges in diagnosing PJI.
- To explore novel diagnostic biomarkers and techniques for PJI.
- To highlight advancements in PJI detection methods.
Main Methods:
- Review of existing literature on PJI diagnostics.
- Analysis of conventional diagnostic criteria including cultures, serum markers, and synovial fluid analysis.
- Investigation of emerging diagnostic approaches: proteomics, synovial fluid biomarkers (α-defensin, IL-6), biofilm-targeted methods, DNA microarrays, and molecular amplification techniques.
Main Results:
- Proteomics and specific synovial fluid biomarkers offer improved accuracy over conventional markers.
- Limitations in traditional microbial cultures necessitate improved sensitivity.
- Novel techniques like biofilm visualization and DNA microarrays show potential for enhanced bacterial detection.
- Molecular methods aid in identifying causative agents in culture-negative PJI.
Conclusions:
- Accurate PJI diagnosis is challenging due to limitations in current methods.
- Emerging biomarkers and advanced molecular techniques represent significant progress in PJI diagnostics.
- These novel approaches could become valuable tools for clinicians in managing PJI.
